Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 21, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

April 1, 2028

Conditions
Pancreatic Ductal AdenocarcinomaOligometastatic Disease
Interventions
PROCEDURE

Surgery

All eligible patients with hepatic metastasis will undergo exploratory laparotomy surgery and synchronous resection of the tumor and hepatic metastases, if feasible according to the surgeon, 2-6 weeks after the last neoadjuvant chemotherapy treatment. All eligible patients with pulmonary metastasis will undergo resection of the primary tumor followed by resection of pulmonary metastases or vice versa, if feasible

Trial Locations (1)

21287

RECRUITING

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER